Humacyte (HUMA) Cash & Equivalents (2020 - 2026)
Humacyte (HUMA) posted Cash & Equivalents of $79.9 million for Q2 2026, up 110.1% from $38.03 million a year earlier and up 64.6% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Humacyte's Cash & Equivalents came in at $50.5 million, up 12.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
- In prior years, Humacyte's Cash & Equivalents was $44.94 million in FY2024 (-44.1%), $80.45 million in FY2023 (-46.3%), $149.77 million in FY2022 (-31.1%) and $217.5 million in FY2021 (+444.7%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q2 2024.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 16.8%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2021, with growth of 444.7%; the weakest was Q3 2024, with a decline of 79.4%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $48.54 million (Q1 2026), $50.5 million (Q4 2025) and $19.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Humacyte | 101.19 Mn | -97.25 Mn | -825,000.00 | 79.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.90 Mn |
| Mar 31, 2026 | 48.54 Mn |
| Dec 31, 2025 | 50.50 Mn |
| Sep 30, 2025 | 19.50 Mn |
| Jun 30, 2025 | 38.03 Mn |
| Mar 31, 2025 | 62.85 Mn |
| Dec 31, 2024 | 44.94 Mn |
| Sep 30, 2024 | 20.60 Mn |
| Jun 30, 2024 | 93.60 Mn |
| Mar 31, 2024 | 115.51 Mn |
| Dec 31, 2023 | 80.45 Mn |
| Sep 30, 2023 | 100.00 Mn |
| Jun 30, 2023 | 114.60 Mn |
| Mar 31, 2023 | 129.57 Mn |
| Dec 31, 2022 | 149.77 Mn |
| Sep 30, 2022 | 163.73 Mn |
| Jun 30, 2022 | 181.04 Mn |
| Mar 31, 2022 | 198.22 Mn |
| Dec 31, 2021 | 217.50 Mn |
| Sep 30, 2021 | 240.45 Mn |
API Access
Humacyte Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();